Randomized Trial of Single-Dose HPV Vaccination in Young Women: 54-Month Efficacy and Durability скачать в хорошем качестве

Randomized Trial of Single-Dose HPV Vaccination in Young Women: 54-Month Efficacy and Durability

In this event titled, Randomized Trial of Single-Dose HPV Vaccination in Young Women: 54-Month Efficacy and Durability, Ruanne Barnabas, MBChB, PhD, Chief of the Division of Infectious Diseases at Massachusetts General Hospital and Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health, presents findings from the KEN SHE Study—a randomized trial in Kenya assessing the efficacy of a single-dose HPV vaccine among young women. The session will explores how a simplified vaccination schedule could transform cervical cancer prevention worldwide, especially in low- and middle-income countries where access to multi-dose regimens is limited. This event is a part of the Global Health Research & Innovation Speaker Series, which showcases the latest scholarly and scientific advancements in global health across Harvard and beyond, to make cutting-edge research accessible to a diverse global audience, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. 🔗 Learn more about the event: https://globalhealth.harvard.edu/even... Speakers’ remarks are based on their own scholarship and experience. As such, they speak for themselves, not for Harvard.